BioPharm International-06-01-2009

Modern bioassays enable more accurate potency testing.

UK-based CMOs seek opportunities in new markets.

Agency officials promise swift action against violators of drug safety and quality regulations.

Importing foreign drugs is not the best way to increase access to medicine. The risks are too high, and it burdens the over-stretched FDA unfairly.

How to maintain product stability and prevent particulates.

A prove-free system monitors accurately at very small scale.

What end users think about single-use systems.

New expression systems compete for attention.